+33 1 76 70 47 90 / creativ@creativ-ceutical.com

An Adjusted indirect comparison of Everolimus and Sofarenib therapy in Sunitinib -Refractory mRCC patients using a robust matching technique

An Adjusted indirect comparison of Everolimus and Sofarenib therapy in Sunitinib -Refractory mRCC patients using a robust matching technique

2010 European Society for Medical Oncology, October 8-10, 2010, Milan, Italy

Di Lorenzo, G. | Casciano, R. | Malangone, E. | Buonerba, C. | Sherman, S. | Wang, X. | Liu, Z. | De Placido, S. | Volume: , Issue: , Pages: , t,